A single-arm, phase II trial assessing the combination of AK105 and anlotinib in first-line treatment for persistent, recurrent, or metastatic cervical cancer

被引：0
|
作者：
Guo, Ruixia [1 ]
Qiu, Haifeng [1 ]
Wang, Qian [1 ]
Su, Ke [1 ]
Chang, Lei [1 ]
Cai, Mingbo [1 ]
Mao, Meng [1 ]
Bian, Aiping [1 ]
机构：
[1] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5530
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase II, open-label, single-arm study of QL1604 plus paclitaxel-cisplatin/carboplatin as first-line treatment in patients with recurrent or metastatic cervical cancer
    Liu, J.
    Fang, C.
    Zhou, Q.
    He, L.
    Yu, J.
    Li, Y.
    Feng, M.
    Pan, M.
    Zhao, L.
    Tang, D.
    Li, X.
    Tan, B.
    An, R.
    Zheng, X.
    Si, M.
    Zhang, B.
    Li, L.
    Kang, X.
    ANNALS OF ONCOLOGY, 2022, 33 : S1506 - S1506
  • [32] A Single-Arm Phase II Study of Anlotinib Combined with Pemetrexed plus Cisplatin as a First-Line Therapy in Advanced NSCLC
    Xiong, J.
    Li, J.
    Deng, J.
    Zhang, W.
    Wang, H.
    Zeng, L.
    Shi, H.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S675 - S676
  • [33] Penpulimab combined with anlotinib and nab-paclitaxel plus gemcitabine (PAAG) as first-line treatment for advanced metastatic pancreatic cancer: A prospective, multicenter, single-arm, phase II study
    Du, J.
    Tong, F.
    Sha, H.
    Sun, Y.
    Zhu, Y.
    Qi, L.
    Li, X.
    Li, W.
    Yang, Y.
    Li, Z.
    Xu, C.
    Ni, J.
    Zhang, X.
    Zhu, C.
    Wang, X.
    Qian, X.
    Liu, B.
    ANNALS OF ONCOLOGY, 2023, 34 : S1535 - S1535
  • [34] Anlotinib combined with CAPEOX in first-line treatment of patients with RAS and BRAF wild-type unresectable metastatic colorectal cancer: A single-arm, phase II study (ALTER-C-002 trial).
    Ding Ke-Feng
    Liu Yue
    Chen Jiaqi
    Sun Lifeng
    Xu Dong
    Liao Xiujun
    Xiao Qian
    Li Jun
    Yuan Ying
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [35] A Phase II Trial of Vinflunine As Monotherapy or in Combination with Trastuzumab as First-Line Treatment of Metastatic Breast Cancer
    Yardley, Denise A.
    McCleod, Michael
    Schreiber, Fred
    Murphy, Patrick
    Patton, Jeffrey
    Thompson, Dana S.
    Shastry, Mythili
    Rubin, Mark
    Melnik, Marianne
    Burris, Howard A.
    Hainsworth, John D.
    CANCER INVESTIGATION, 2010, 28 (09) : 925 - 931
  • [36] Anlotinib combined with penpulimab as first-line treatment for persistent, recurrent, or metastatic cervical cancer: Preliminary results from ALTER-GO-020, a single-arm, open-label, multi-cohort, multi-center phase II clinical study.
    Wang, Dengfeng
    Liu, Hong
    Chen, Lihong
    He, Mian
    Zhao, Weidong
    Xiang, Yang
    Zhang, Guonan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] Safety and efficacy of endostar combined with platinum-based chemotherapy in the first-line treatment of recurrence and metastatic cervical cancer: A single-arm, prospective phase II study
    Zhou, J.
    Wang, L.
    Zhuang, H.
    Qin, S.
    Xu, X.
    ANNALS OF ONCOLOGY, 2021, 32 : S754 - S754
  • [38] Anlotinib plus everolimus as first-line treatment for advanced non-clear cell renal cell carcinoma: A single-center, single-arm, phase II trial
    Zhang, Hailiang
    Ye, Dingwei
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [39] A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer
    Kim, Hye Ryeon
    Lee, Su Jin
    Park, Sehhoon
    Jung, Hyun Ae
    Lee, Se-Hoon
    Jeong, Han-Sin
    Chung, Man Ki
    Ahn, Myung-Ju
    CANCER RESEARCH AND TREATMENT, 2022, 54 (03): : 719 - 727
  • [40] A Phase II, Single-Arm, Prospective Clinical Trial for the Efficacy and Safety of Apatinib Combined With Capecitabine in Therapy for Recurrent/Metastatic and Persistent Cervical Cancer After Radiochemotherapy
    Li, J.
    Mao, W.
    Li, F.
    Ran, L.
    Chang, J.
    Mei, F.
    Hu, L.
    Du, Y.
    Tian, X.
    Liu, M.
    Chen, Y.
    Shan, L.
    Mu, J.
    Yin, S.
    Qin, Y.
    Liang, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E616 - E617
12345